Carlo Lanza 医師 / 博士

Carlo Lanza 医師 / 博士
医務執行責任者

Carlo Lanza, MD, PhD, is executive medical officer for Labcorp Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase I-IV clinical trials for Labcorp clients. He leads early phase and translational research early development programs with targeted therapies, small molecules, biologics and gene therapy. Dr. Lanza also oversees development of late-stage development strategies and delivery and approval of registrational programs. 医師、医療ディレクターとして 20年以上臨床研究開発に携わってきており、小児疾患とオンコロジーを専門としています。 Before joining Labcorp, he served as medical director for medicines at Malaria Venture in Geneva, Switzerland. Dr. Lanza also has held leadership positions with Novartis Oncology, Pfizer Global Research and Development, and AstraZeneca U.K. He joined Labcorp in 2012.

お問い合わせはこちら

お問い合わせ